In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1alpha and TNF-alpha

J Cutan Med Surg. 1999 Jan;3(3):140-4. doi: 10.1177/120347549900300306.

Abstract

Background: Pemphigus vulgaris (PV) is a potentially life-threatening disease, characterized immunohistologically by IgG deposits and complement activation on the surface of keratinocytes. Complement activation has been implicated in the pathogenesis with C3 deposits in about 90% of patients.

Objective: In order to further elucidate the role of complement in PV and to define which cytokines play a role in C3 mRNA expression, we performed an in vitro study in human keratinocytes.

Methods: Normal human epidermal keratinocytes (NHuK) were incubated with PV serum and C3 mRNA was measured. We previously had shown that IL-1alpha and TNF-alpha are expressed in PV in vivo and in vitro. Since cytokines are able to modulate complement activation, mRNA expression was evaluated in a similar experiment after pretreatment using antibodies against IL-1alpha and TNF-alpha.

Results: Incubation of NHuK with PV sera caused their detachment from the plates after 20-30 minutes with a complete acantholysis within 12 hours. An early C3 mRNA expression was seen after 30 minutes with a peak level after 1 hour. Blocking studies, using antibodies against human IL-1alpha and TNF-alpha in NHuK together with PV-IgG, showed reduction of in vitro induced acantholysis and inhibition of C3 mRNA expression.

Conclusion: This study supports the hypothesis that complement C3 is important in PV acantholysis and that complement activation is increased by IL-1alpha and TNF-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acantholysis / pathology
  • Cells, Cultured
  • Complement Activation / drug effects*
  • Complement C3 / biosynthesis*
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / pharmacology*
  • Keratinocytes / metabolism
  • Pemphigus / metabolism*
  • Pemphigus / pathology
  • RNA, Messenger / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Complement C3
  • Interleukin-1
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha